Ishan Crawford India’s Ministry of Health and Family Welfare has thrown open its draft National Health Research Policy for public comment, with suggestions due by July 27. The draft proposes a National Health Research Agenda, or NHRA, as the country’s central framework for coordinating research priorities, arriving at a moment when India still spends just 0.02% of its GDP on health research, well below the 0.1% share its own parliamentary Standing Committee recommended.
The harder question is whether a new framework can succeed where an almost identical one, written fifteen years earlier, did not.
A Single Framework For A Fragmented System
The ministry says the policy is meant to foster a trusted, inclusive, self-reliant and impact-oriented research ecosystem that responds to people’s actual healthcare needs. It wants research that is high quality, ethical and innovative, aimed at both long-standing national priorities and threats that haven’t fully emerged yet.
At the center of the plan sits the National Health Research Agenda itself, meant to work as a shared reference for government scientific departments, research institutions, states and union territories as each sets its own priorities. The Department of Health Research would serve as the nodal department preparing, coordinating and periodically revising that agenda, guided by a new National Health Research Stewardship Committee. The Indian Council of Medical Research, known as ICMR, the country’s main biomedical research body, stays on as the principal agency actually carrying the agenda out. The draft also floats new National Health Research Missions, cross-department programs meant to tackle major health problems that no single ministry can solve alone.
The draft names specific health burdens it wants research to target first:
- Tuberculosis and vector-borne diseases
- Antimicrobial resistance
- Mental health and non-communicable diseases, including cancer
- Anaemia and child malnutrition
- Women’s health, maternal and neonatal mortality
- Primary health care and emergency care
Newer fields get their own carve-out too. The draft flags digital health, artificial intelligence and data science, cell and gene therapy, obesity and climate change as areas it wants prioritized going forward, tying the whole exercise to Viksit Bharat 2047, the government’s long-term development roadmap aimed at the hundredth year of independence. The text also commits to cutting the regulatory delays that slow funded research and treats publicly funded lab infrastructure as a shared national asset rather than one institution’s private stock.
How Much Does India Actually Spend on Health Research?
India spent just 0.02% of its gross domestic product on health research in 2021-22, according to the Standing Committee on Health and Family Welfare’s 2023 report. The panel recommended raising that to 0.1% of GDP, still far short of the 0.65% the United States and 0.44% the United Kingdom spent on health research back in 2017.
That gap sits underneath everything the new draft proposes. Here’s how the main figures compare:
| Metric | Figure | Period |
|---|---|---|
| India’s health research spend (share of GDP) | 0.02% | 2021-22 |
| Standing Committee’s recommended target | 0.1% of GDP | 2023 recommendation |
| United States health research spend | 0.65% of GDP | 2017 |
| United Kingdom health research spend | 0.44% of GDP | 2017 |
| ICMR budget | Rs 4,000 crore | Budget Estimate 2026-27 |
| Department of Health Research total budget | Rs 4,821 crore | Budget Estimate 2026-27 |
The increases on paper are real. ICMR’s budget climbed to Rs 4,000 crore (roughly $480 million) for 2026-27, an increase of Rs 850 crore over the prior year’s revised estimate, the ministry said in its budget breakdown for the Ministry of Health and Family Welfare. That works out to a jump of nearly 27% in a single year. But the Standing Committee’s own 2023 review, cited in a PRS Legislative Research analysis of health spending, found that ICMR’s entire research budget made up just 3% of all research expenditure by the central government back in 2020-21. A single-year jump in one agency’s allocation doesn’t close a gap that size.
A Policy India Already Wrote Once, in 2011
This isn’t India’s first attempt at this rulebook. A National Health Research Policy released in 2011 diagnosed nearly the same problems the 2026 draft now describes: a research system concentrated in a handful of institutions, thin translation of findings into actual programs, and weak surveillance infrastructure. At the time, 96% of the country’s research publications came out of just nine medical colleges, according to the 2011 policy document hosted by the World Health Organization, using figures from 2007.
Fifteen years on, the new draft reads like a rewrite of the same complaint. It acknowledges that research priorities still aren’t always aligned with the country’s most pressing health needs, that administrative and regulatory processes continue to delay funded projects, and that translation from evidence into policy and clinical practice remains uneven. It even flags that assessment systems still lean on conventional academic metrics that don’t capture the fuller value of research, which is precisely the gap the earlier policy tried and largely failed to close.
Delhi Sets the Frame, States Fill It In
States get flexibility rather than a single mandate. The draft says regions may build research coordination capacity in stages, based on institutional readiness, and where a state already runs a health research council or similar body, that body can serve as the stewardship mechanism without anyone building something new.
ICMR already runs a smaller version of this model. Its existing National Health Research Programme funds work across eleven priority disease conditions, with up to 33 projects funded at up to Rs 25 crore each through a competitive call for proposals. The new agenda would essentially scale that same logic nationwide, layering it under the stewardship committee and whatever bodies the states themselves build.
Comments Close July 27, Implementation Comes Later
The public comment window on the draft closes July 27. Whatever survives that process still has to work inside the existing Department of Health Research budget of Rs 4,821 crore for 2026-27, a figure that is 23% higher than the prior year’s revised estimate, according to PRS Legislative Research, though the slice earmarked specifically for research infrastructure, things like epidemic labs and outbreak-tracking tools, rose only 2%, to Rs 241 crore.
What We Know
- Public comments on the draft close July 27, 2026.
- The Department of Health Research is the nodal authority; ICMR remains the principal implementing agency.
- The underlying agenda is designed to be reviewed at intervals of no more than five years once it’s running.
What’s Unconfirmed
- Whether the policy brings fresh money beyond existing budget lines.
- How states without an existing research council will be resourced to build one.
- How the draft’s new multidimensional assessment metrics will actually be scored.
Once finalized, the policy is meant to roll out through phased, adaptive action rather than fixed deadlines, leaving most of the hard choices, including how much new money actually follows, for later.
Frequently Asked Questions
How Can the Public Submit Comments on the Draft Policy?
The Department of Health Research has posted the draft on its own site and is collecting public feedback through its public consultation page ahead of the July 27 cutoff. The ministry says the draft itself already reflects an earlier, closed-door round of stakeholder consultations, meaning this public window is the second layer of input, not the first.
How Does This Differ From the National Health Policy, 2017?
The National Health Policy, 2017 sets broader universal health coverage goals and recommends overall government health spending reach 2.5% of GDP; actual government health expenditure was estimated at only about 2% of GDP in 2022-23. The new draft is narrower by design. It deals only with the research ecosystem, funding architecture and institutional stewardship, not the wider health-spending target.
Does the Draft Commit India to a Specific Research Spending Target?
No. The draft’s own language says investment in health research is “intended to rise,” with support from private and philanthropic funding, but it names no rupee figure or GDP share. That’s notable because the same 2026-27 budget found room for a specific, dated commitment elsewhere: a Rs 10,000 crore, five-year outlay for a new biopharmaceutical manufacturing push called Bio Pharma Shakti. Hard numbers were available when the government chose to write them in.
What Are the National Health Research Missions?
They’re a new structure proposed in the draft: dedicated missions built around major health challenges that cut across departments and can’t be solved by any single ministry or institute acting alone. The draft ties them to the broader National Health Research Agenda but treats them as a separate delivery mechanism for problems judged too large for routine grant funding.
Is the Policy Final, or Could It Still Change?
It’s still a draft. Public comments remain open until July 27, and the health ministry has not announced a date for when a final, notified version will be issued. Everything described in the current text, including disease priorities and governance structure, remains subject to revision based on the feedback the ministry receives.
Brent Crude Hits a One-Month High as US-Iran Strikes Rattle Hormuz 
Foreign Investors Return With $2.5 Billion as Domestic Funds Take Charge 
Flying Fijians Face a Scrum Reckoning Before Scotland Test 
India’s Ethanol Blending Push May Keep Petrol Prices High 
Marie Maitland’s Hidden Love Poems Cast Her as Scotland’s Anne Lister 
Edinburgh’s New Tourist Tax Hides Europe’s Quiet Housing Bet